AHPC 4in1 Test Kits – 600/CTN
NASAL TEST
600 Tests per CARTON
This 4-in-1 lateral flow immunoassay provides a multiplexed platform for the detection of SARS-CoV-2, respiratory syncytial virus (RSV), influenza A, and influenza B viral nucleoprotein antigens in nasal swab samples. The assay is intended for use in non-laboratory settings and offers clear, interpretable results to aid in the diagnosis of SARS-CoV-2 infection within the initial 7 days of symptom presentation, and influenza A/B and RSV infections within the first 4 days of symptom presentation.
COVID-19: 97.55%
FLU A: 97.14%
FLU B: 96.26%
RSV: 96.66%
- Four-target immunoassay with a clear, three-panel readout.
- Simultaneous detection of SARS-CoV-2, Respiratory Syncytial Virus (RSV), Influenza A, and Influenza B.
- Rapid results delivered within 15 minutes.
- Utilizes nasal swab specimens for collection.
- Requires only 3 drops of processed sample per test panel.












